Perioperative venous thromboembolism prophylaxis: short review and recommendations;Thromboprophylaxie périopératoire : brève revue et recommandations

Annales Francaises d'Anesthesie et de Reanimation

Volumn 27, Issue SUPPL. 3, 2008, Pages

  Samama, C M ^a  

^a HÔTEL DIEU   (France)

Author keywords

Bleeding risk, Rivaroxaban; Deep vein thrombosis; Fondaparinux; Low molecular weight heparins; Prophylaxis; Pulmonary embolism; Surgery guidelines

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; DABIGATRAN; DANAPAROID; DEXTRAN; FLUINDIONE; FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; WARFARIN;

ABDOMINAL SURGERY; ARTICLE; BLEEDING; BODY WEIGHT; CARDIOVASCULAR RISK; COMPRESSION THERAPY; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; EPIDURAL HEMATOMA; HIP FRACTURE; HUMAN; KIDNEY FUNCTION; MOBILIZATION; PATHOPHYSIOLOGY; PERIOPERATIVE COMPLICATION; PROPHYLAXIS; RISK FACTOR; SPINAL HEMATOMA; SURGICAL RISK; TOTAL HIP PROSTHESIS; ULTRASOUND; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; ANTICOAGULANTS; COMBINED MODALITY THERAPY; FIBRINOLYTIC AGENTS; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MIDDLE AGED; MORPHOLINES; POLYSACCHARIDES; POSTOPERATIVE COMPLICATIONS; PREANESTHETIC MEDICATION; PULMONARY EMBOLISM; RISK FACTORS; STOCKINGS, COMPRESSION; THIOPHENES; THROMBOEMBOLISM; THROMBOPHLEBITIS; VITAMIN K;

EID: 58649098536     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(08)75140-2     Document Type: Article

References (32)

1. Committee. HoCH. The prevention of venous thromboembolism in hospitalised patients (2005), The Stationery Office Limited, London
2. Geerts W.H., Pineo G.F., Heit J.A., Bergqvist D., Lassen M.R., Colwell C.W., et al. Prevention of venous thromboembolism : the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3Suppl (2004) 338S-400S
3. Geerts W.H., Bergqvist D., Pineo G.F., Heit J.A., Samama C.M., Lassen M.R., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 6Suppl (2008) 381S-453S
4. Samama C.M., Albaladejo P., Laversin S., and Marret E. Prevention of venous thromboembolism in surgery and obstetrics. Ann Fr Anesth Reanim 24 (2005) 853-861
5. Samama C.M., Albaladejo P., Benhamou D., Bertin-Maghit M., Bruder N., Doublet J.D., et al. Venous thromboembolism prevention in surgery and obstetrics: clinical practice guidelines. Eur J Anaesthesiol 23 (2006) 95-116
6. Heit J.A. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost 3 (2005) 1611-1617
7. Hill J., and Treasure T. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients having surgery: summary of NICE guidance. BMJ 334 (2007) 1053-1054
8. Bergqvist D., and Lowe G. Venous thromboembolism in patients undergoing laparoscopic and arthroscopic surgery and in leg casts. Arch Intern Med 162 (2002) 2173-2176
9. Sors H., Safran D., Stern M., Reynaud P., Bons J., and Even P. An analysis of the diagnostic methods for acute pulmonary embolism. Intensive Care Med 10 (1984) 81-83
10. Weitz J.I. Factor Xa or thrombin: is thrombin a better target?. J Thromb Haemost 5 Suppl 1 (2007) 65-67
11. Kehlet H. Future perspectives and research initiatives in fast-track surgery. Langenbecks Arch Surg 391 (2006) 495-498
12. White R.H., Zhou H., and Romano P.S. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 90 (2003) 446-455
13. Rosencher N., Vielpeau C., Emmerich J., Fagnani F., and Samama C.M. Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE study. J Thromb Haemost 3 (2005) 2006-2014
14. Amaragiri S.V., and Lees T.A. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 3 (2000) CD001484
15. Ansell J., Hirsh J., Hylek E., Jacobson A., Crowther M., and Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 6 Suppl (2008) 160S-198S
16. Samama C.M., Vray M., Barre J., Fiessinger J.N., Rosencher N., Lecompte T., et al. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant. Arch Intern Med 162 (2002) 2191-2196
17. Mismetti P., Laporte S., Zufferey P., Epinat M., Decousus H., and Cucherat M. Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis. J Thromb Haemost 2 (2004) 1058-1070
18. Hirsh J., Bauer K.A., Donati M.B., Gould M., Samama M.M., and Weitz J.I. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 Suppl 6 (2008) 141S-159S
19. Hirsh J., and Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 Suppl 3 (2004) 188S-203S
20. Warkentin T.E., Greinacher A., Koster A., and Lincoff A.M. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 Suppl 6 (2008) 340S-380S
21. Turpie A.G., Bauer K.A., Eriksson B.I., and Lassen M.R. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 162 (2002) 1833-1840
22. Samama M.M. Les nouveaux antithrombotiques. Presse Med 34 (2005) 1309-1314
23. Warkentin T.E., Maurer B.T., and Aster R.H. Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med 356 (2007) 2653-2655 discussion-5
24. Eriksson B.I., Dahl O.E., Rosencher N., Kurth A.A., van Dijk C.N., Frostick S.P., et al. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost 5 (2007) 2178-2185
25. Eriksson B.I., Dahl O.E., Rosencher N., Kurth A.A., van Dijk C.N., Frostick S.P., et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement : a randomised, double-blind, non-inferiority trial. Lancet 370 (2007) 949-956
26. Lassen M.R., Ageno W., Borris L.C., Lieberman J.R., Rosencher N., Bandel T.J., et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 358 (2008) 2776-2786
27. Lassen M.R., Davidson B.L., Gallus A., Pineo G., Ansell J., and Deitchman D. The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement. J Thromb Haemost 5 (2007) 2368-2375
28. Eriksson B.I., Borris L.C., Friedman R.J., Haas S., Huisman M.V., Kakkar A.K., et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 358 (2008) 2765-2775
29. Weitz J.I., Hirsh J., and Samama M.M. New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 Suppl 6 (2008) 234S-256S
30. Quinlan D.J., Eikelboom J.W., Dahl O.E., Eriksson B.I., Sidhu P.S., and Hirsh J. Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery. J Thromb Haemost 5 (2007) 1438-1443
31. Committee for Medicinal Products for Human Use. Draft guideline on clinical investigation of medicinal products for prophylaxis of high intra- and post-operative venous thromboembolic risk. EMEA 2006 http://www.emea.europa.eu/pdfs/human/ewp/70798en.pdf.
32. Mismetti P., Zufferey P., Pernod G., Baylot, Estebe J.P., Barrelier M.T., et al. Thromboprohylaxis in orthopedic surgery and traumatology. Ann Fr Anesth Reanim 24 (2005) 871-889